News

Stopping aspirin 1 month after coronary stenting significantly reduces bleeding complications in heart attack patients

08 Apr: Stopping aspirin 1 month after coronary stenting significantly reduces bleeding complications in heart attack patients

The primary efficacy endpoint of clinically-relevant bleeding, defined as BARC types 2, 3 or 5 bleeding, was assessed in the intention-to-treat population between one-month and twelve-months post-PCI in patients who were event-free after one month of ticagrelor and aspirin. Switching to ticagrelor monotherapy at one month resulted in a 55-percent reduction in the hazard of

Clinical trial: First cardiac bioimplants for treatment of myocardial infarction using umbilical cord stem cells

05 Apr: Clinical trial: First cardiac bioimplants for treatment of myocardial infarction using umbilical cord stem cells

The results of a pioneering study support the safety of the bioimplants called PeriCord, made from stem cells of the umbilical cord and pericardium from a tissue donor, which aid in the regeneration and revascularization of the affected area. The study has monitored seven interventions of this pioneering tissue engineering surgery over three years…

Long-distance and low-attenuation magnetic energy focusing technology for deep-tissue wireless powering

04 Apr: Long-distance and low-attenuation magnetic energy focusing technology for deep-tissue wireless powering

Editors’ notes This article has been reviewed according to Science X’s editorial process and policies. Editors have highlighted the following attributes while ensuring the content’s credibility: fact-checked trusted source proofread by Science China Press (a1) System design of the ULFMEF developed for wireless charging of implantable electronic devices, where the ULFMEF system consisted of an IMER

UK study identifies ideal weight for adults with type 2 diabetes to minimize risk of dying from cardiovascular disease

30 Mar: UK study identifies ideal weight for adults with type 2 diabetes to minimize risk of dying from cardiovascular disease

Credit: PhotoMIX Company from Pexels New research being presented at this year’s European Congress on Obesity (ECO) in Venice, Italy (12–15 May), identifies the optimum body weight range for adults with type 2 diabetes to minimize their risk of dying from any cardiovascular disease, including heart failure, heart disease, stroke, and chronic kidney disease. The